Back
Raffles Medical Group Vs. CytoMed Therapeutics Industry Stock Comparison
Sell
44
RAFLF
Raffles Medical Group
Last Price:
0.67
Seasonality Move:
0.85%
Buy
62
GDTC
CytoMed Therapeutics
Last Price:
2.20
Seasonality Move:
-35.48%
Sell
44
Raffles Medical Group (RAFLF)
is a Sell
Is Raffles Medical Group a Buy, Sell or Hold?
- The current Raffles Medical Group [RAFLF] share price is $0.67. The Score for RAFLF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- RAFLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
CytoMed Therapeutics (GDTC)
is a Buy
Is CytoMed Therapeutics a Buy, Sell or Hold?
- The current CytoMed Therapeutics [GDTC] share price is $2.26. The Score for GDTC is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- GDTC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RAFLF Stock Price Chart
What is Raffles Medical Group's stock price today?
-
The Raffles Medical Group share price today is $0.67
The current trend is relatively stagnant and RAFLF is experiencing slight buying pressure.
GDTC Stock Price Chart
What is CytoMed Therapeutics's stock price today?
-
The CytoMed Therapeutics share price today is $2.26
The current trend is relatively stagnant and GDTC is experiencing slight buying pressure.
RAFLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 74.22 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.67 - 0.67) | Buy |
| Bollinger Bands (100): | (0.64 - 0.72) | Sell |
GDTC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.08 | Buy |
| Chaikin Money Flow: | 1065 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.13 - 2.63) | Sell |
| Bollinger Bands (100): | (1.56 - 2.28) | Buy |
RAFLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Sell |
| 20-day SMA: | 0.67 | Sell |
| 50-day SMA: | 0.67 | Buy |
| 200-day SMA: | 0.71 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.67 | Buy |
| 50-day EMA: | 0.67 | Sell |
| 200-day EMA: | 0.72 | Sell |
GDTC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.14 | Buy |
| 20-day SMA: | 2.3 | Sell |
| 50-day SMA: | 2.07 | Buy |
| 200-day SMA: | 2.03 | Buy |
| 8-day EMA: | 2.19 | Buy |
| 20-day EMA: | 2.24 | Buy |
| 50-day EMA: | 2.13 | Buy |
| 200-day EMA: | 2.22 | Buy |
Raffles Medical Group Earnings Growth & RAFLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
CytoMed Therapeutics Earnings Growth & GDTC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
Raffles Medical Group Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CytoMed Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||